Table 2.
Genotype | Psoriasis (N = 94) | Control (N = 200) | P value | RR | EF*/PF | ||
---|---|---|---|---|---|---|---|
N | Freq. % | N | Freq. % | ||||
ε3/ε3 | 66 | 70.21 | 183 | 91.50 | 0.0001† | 0.219 | 0.486 |
ε3/ε4 | 20 | 21.28 | 17 | 8.50 | 0.0040† | 2.910 | 0.354* |
ε3/ε2 | 8 | 8.51 | 0 | 0 | 0.0001† | — | — |
ε2/ε4 | 0 | 0 | 0 | 0 | — | — | — |
ε2/ε2 | 0 | 0 | 0 | 0 | — | — | — |
ε4/ε4 | 0 | 0 | 0 | 0 | — | — | — |
†Statistically significant; N: number of subjects; RR: relative risk; EF: etiological fraction; PF: preventive fraction.